Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, June 2005, p. 2519-2521, Vol. 49, No. 6
0066-4804/05/$08.00+0 doi:10.1128/AAC.49.6.2519-2521.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
National Institute of Infectious Diseases, Shinjuku, Tokyo 162-8640,1 Department of Research and Development, Fuji Latex Co., Ltd., Tochigi, Tochigi 328-0006,2 Department of Pediatrics, Saitama Medical School, Iruma, Saitama 350-0495,3 Department of Pediatrics 2, Kawasaki Medical School, Kurashiki, Japan4
Received 4 October 2004/ Returned for modification 14 December 2004/ Accepted 18 February 2005
The inhibitory effects of hinokitiol (ß-thujaplicin) on Chlamydia trachomatis D/UW-3/Cx were shown by MIC, minimum lethal concentration (MLC), and preinoculation minimal microbicidal concentration assays using HeLa 229 cells. The MIC and the MLC were both 32 µg/ml. Further evaluation of hinokitiol as a topical agent against C. trachomatis is warranted.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»